Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: The intervention group will receive (naproxene 500mg 3times a day) for 10 days and vit B1 B6 tabs for 6month.They use splint for 6 months. Intervention 2: The control group:The patient
Rehabilitation
The intervention group will receive (naproxene 500mg 3times a day) for 10 days and vit B1 B6 tabs for 6month.They use splint for 6 months
The control group:The patients use splint for 6 weeks.They will receive (naproxene 3 times a day) for 10 days and Vit B1 B6 for 6 months .
Sponsors
Vice chancellor for research ,Shiraz University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient with severe cts that did not accept surgical treatment Exclusion criteria:patient with previous surgery on the study hand or wrist; any mass; tumor; or deformity in the hand or wrist; any history of severe trauma to the wrist (such as fracture); polyneuropathy; cervical radiculopathy; pregnancy; or lactating; fibromyalgia; arthritis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EMG and NCV are the primary outcomes measurements that at the end they determinate the efficacy of the splint for the study. Timepoint: at the begining and at the end. Method of measurement: CTSAQ,Boston questionaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical manifestations. Timepoint: every 2 weeks. Method of measurement: physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahrzad Sanaee
International branch of Shiraz University of Medical Science
Outcome results
None listed